Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33769?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011221
Suicide Among Individuals With Autism Spectrum Disorder
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 12, 2021
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33565?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011221
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: National register data from Denmark were used to examine if people with autism spectrum disorder (ASD) have higher rates of suicide attempts and suicide compared to those without ASD and to identify potential risk factors.
Author: Kairi Kõlves, Ph.D., of Griffith University in Brisbane, Australia, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33565)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33157?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011121
Pediatric Hospitalizations for COVID-19
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 11, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5535?guestAccessKey=1762b684-6426-4734-a8a8-f583eb762f5b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011121
What The Study Did: Researchers examined pediatric COVID-19 hospitalization trends in 22 states for both severity among this population and spread of the virus.
Authors: Pinar Karaca-Mandic, Ph.D., of the University of Minnesota Carlson School of Management in Minneapolis, is the corresponding author.
(doi:10.1001/jamapediatrics.2020.5535)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Clinical Trial of Antibiotic Strategies for Uncomplicated Acute Appendicitis
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 11, 2021
Media advisory: The full study and editorial are linked to this news release. A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23525?guestAccessKey=5f6b0eb2-50eb-4a97-b06c-00b0630c9d51&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011121
What The Study Did: This randomized clinical trial compares the effects of two antibiotic strategies (oral moxifloxacin versus intravenous ertapenem followed by oral levofloxacin) on hospital discharge without surgery and recurrent appendicitis over one year among adults presenting to the emergency department with uncomplicated acute appendicitis.
Authors: Paulina Salminen, M.D., Ph.D., of Turku University Hospital in Turku, Finland, is the corresponding author.
Visual Abstract
(doi:10.1001/jama.2020.23525)
Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5342?guestAccessKey=6b663830-756f-4520-ab7e-f6ab186b5f14&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011121
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32681?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011121
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30832?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=011121
Rate of Neonatal Abstinence Syndrome, Maternal Opioid-Related Diagnoses in US
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 12, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24991?guestAccessKey=83bccccd-b9e4-4601-8a84-c5f590385836&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011221
What The Study Did: Variations and changes in national and state rates of neonatal abstinence syndrome and maternal opioid-related diagnoses were examined in this observational study.
Authors: Ashley H. Hirai, Ph.D., of the Health Resources and Services Administration in Rockville, Maryland, is the corresponding author.
(doi:10.1001/jama.2020.24991)
Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32779?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010821
Measuring Racial Inequities in COVID-19 Testing
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JANUARY 8, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32696?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010821
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This study adapted a well-established tool for measuring inequity from economics—the Lorenz curve—to measure racial inequities in COVID-19 testing.
Author: Aaloke Mody, M.D., of the Washington University School of Medicine in St Louis, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.32696)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Race in Clinician Documentation
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 11, 2021
Media advisory: The full study and editor’s note are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.5792?guestAccessKey=a1b54770-3400-4e14-a25c-e85cca4ebea6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011121
What The Study Did: Medical records for patients admitted to an urban academic medical center were analyzed for race and ethnicity for evidence of racial bias in clinician documentation.
Authors: Jessica R. Balderston, M.D., of Virginia Commonwealth University Medical Center in Richmond, is the corresponding author.
(doi:10.1001/jamainternmed.2020.5792)
Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31073?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010721
SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.35057?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010721
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Under a range of assumptions of presymptomatic transmission and transmission from individuals with infection who never develop symptoms, the model presented here estimated that more than half of transmission comes from asymptomatic individuals.
Author: Jay C. Butler, M.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.35057)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessment of Duplicate Evidence in Systematic Reviews of Imaging Findings of Children With COVID-19
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32769?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010721
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did:This cross-sectional study maps a coronavirus research question to illustrate the overlap and shortcomings of the evidence syntheses in this area.
Author: Giordano Pérez-Gaxiola, M.D., M.Sc., of Sinaloa Pediatric Hospital’s Cochrane Associate Centre in Culiacan, Mexico, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.32769)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Virtual Care At Cancer Center During COVID-19
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6982?guestAccessKey=3851b32e-6501-489b-ac60-39e8281b62a8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
What The Study Did: The outcomes of a cancer center-wide virtual care program launched in response to the COVID-19 pandemic were examined in this study.
Authors: Alejandro Berlin, M.D., M.Sc., of the Princess Margaret Cancer Centre in Toronto, Ontario, Canada, is the corresponding author.
(doi:10.1001/jamaoncol.2020.6982)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Adapting to COVID-19 With Outdoor Intraocular Pressure Monitoring
JAMA Ophthalmology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.6073?guestAccessKey=57d89ee8-3fb5-4fc6-8eb1-498769b5540b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
What The Study Did: To adapt to broader public health initiatives around COVID-19, researchers developed a drive-through intraocular pressure (IOP) screening clinic to minimize COVID-19 exposure for patients and clinicians by measuring eye pressure in the unconventional setting of a clinic parking lot.
Authors: Miel Sundararajan, M.D., of the University of California, San Francisco, is the corresponding author.
(doi:10.1001/jamaophthalmol.2020.6073)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6758?guestAccessKey=7d0970dc-4d97-458c-8b06-c765db479414&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
Examining Association of Age, Household Dysfunction, Outcomes in Early Adulthood
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32769?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010721
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Population data from Denmark were used to examine whether age at exposure to negative experiences in childhood and adolescence (parents’ unemployment, incarceration, mental disorders, death and divorce, and the child’s foster care experiences) was associated with outcomes in early adulthood.
Author: Signe Hald Andersen, Ph.D., of the Rockwool Foundation Research Unit in Copenhagen, Denmark, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.32769)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6789?guestAccessKey=87987059-df65-4f70-abff-8360f6ebb2ef&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
Speech Recognition Changes After Cochlear Implant
JAMA Otolaryngology–Head & Neck Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.5094?guestAccessKey=b6a3f146-3859-40cd-a8f0-3e70b3c92c48&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
What The Study Did: Researchers compared changes in preoperative aided speech recognition with postoperative speech recognition among individuals who received cochlear implants.
Authors: Theodore R. McRackan, M.D., M.S.C.R., of the Medical University of South Carolina in Charleston, is the corresponding author.
(doi:10.1001/jamaoto.2020.5094)
Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Out-of-Hospital Cardiac Arrests, Fatalities in Detroit Area During COVID-19 Pandemic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JANUARY 6, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32331?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010621
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Changes in out-of-hospital cardiac arrests and fatalities in the Detroit area during the COVID-19 pandemic are compared with year-earlier events for the same period in this observational study.
Authors: Adrienne V. Nickles, M.P.H., of the Michigan Department of Health and Human Services in Lansing, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.32331)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Maps, Public Knowledge, Risk Perceptions and Behavioral Intentions
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JANUARY 6, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33538?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010621
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: The findings of this survey study suggest that simply providing maps with COVID-19 case information wasn’t necessarily associated with improved public knowledge, risk perception or reported intent to adhere to health guidelines.
Authors: Angela Fagerlin, Ph.D., of the University of Utah in Salt Lake City, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33538)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Changes in Abortion in Texas Following Executive Order Ban During Pandemic
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24096?guestAccessKey=1a9d0b9c-7889-460f-839e-326b29d61634&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
What The Study Did: Changes were assessed in abortions performed and at what gestational age following a Texas order postponing nonmedically necessary surgeries due to the COVID-19 pandemic compared with abortions performed during the same months in 2019.
Authors: Kari White, Ph.D., M.P.H., of the University of Texas at Austin, is the corresponding author.
(doi:10.1001/jama.2020.24096)
Editor’s Note: The articles includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Public Health Messaging in Era of Social Media
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24514?guestAccessKey=63352c09-e602-441a-b8af-d8feac1683cc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
What The Viewpoint Says: The rapid spread of scientific misinformation on social media platforms throughout the COVID-19 pandemic is discussed in this Viewpoint, which also proposes strategies to counteract its adverse effects including surveillance of digital data and partnering with trusted messengers to engage the public and advance scientifically sound public health measures.
Authors: Raina M. Merchant, M.D., M.S.H.P., of the University of Pennsylvania in Philadelphia, is the corresponding author.
(doi:10.1001/jama.2020.24514)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Public Concern About Violence, Firearms, COVID-19 Pandemic in California
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33484?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010421
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: The findings of a survey study using data from California suggests the COVID-19 pandemic was associated with increases in self-reported worry about violence for oneself and others, increased firearm acquisition and changes in firearm storage practices.
Authors: Nicole Kravitz-Wirtz, Ph.D., M.P.H., University of California Firearm Violence Research Center and Violence Prevention Research Program, Department of Emergency Medicine, University of California Davis School of Medicine in Sacramento, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33484)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Public Mobility, Social Media Attention in Response to COVID-19 in Sweden, Denmark
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33478?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010421
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Denmark was one of the first countries to enforce lockdown to reduce the spread of COVID-19 and subsequent gradual reopening, whereas Sweden has had few restrictions, largely limited to public recommendations. Researchers assessed public mobility and social media attention associated with COVID-19 spread and societal interventions from February to June in Denmark and Sweden.
Authors: Isabell Brikell, Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33478)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7238?guestAccessKey=dabc4171-7f0d-4a19-8bbc-b5e21746f4af&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7235?guestAccessKey=870e5d53-7b6e-4f26-9d21-3d84e3b48dbb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, Deaths
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JANUARY 5, 2021
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33706?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=010521
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Data from public health surveillance of reported COVID-19 cases and seroprevalence surveys were used in this observational study that reports an estimated 46.9 million SARS-CoV-2 infections, 28.1 million symptomatic infections, 956,174 hospitalizations and 304,915 deaths occurred in the U.S. through November 15, 2020.
Authors: Frederick J. Angulo, D.V.M., Ph.D., of Medical Development and Scientific/Clinical Affairs of Pfizer Vaccines, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33706)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7968?guestAccessKey=debfbb69-0f1c-45b8-8213-4fbec3178bda&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
What The Study Did: In this observational study of 5,256 U.S. nursing home residents with COVID-19, increased age, male sex and impaired cognitive and physical function were independent risk factors for all-cause 30-day mortality.
Authors: Orestis A. Panagiotou, M.D., Ph.D., of the Brown University School of Public Health in Providence, Rhode Island, is the corresponding author.
(doi:10.1001/jamainternmed.2020.7968)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Risk of Substance Use Disorder Among Patients With Autism
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, JANUARY 4, 2021
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5371?guestAccessKey=c6dd8dcf-daf6-427f-bd94-e126b67fc46d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010421
What The Study Did: Researchers used health insurance data from Taiwan to investigate the risk of substance use disorder among patients with autism spectrum disorder and its associations with risk of death.
Authors: Chih-Sung Liang, M.D., of the National Defense Medical Center, and Mu-Hong Chen, M.D., Ph.D., of the Taipei Veterans General Hospital in Taipei, Taiwan, are the corresponding authors.
(doi:10.1001/jamapediatrics.2020.5371)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Hidden Epidemic of Opioid Overdoses During COVID-19 Pandemic
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 30, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.4148?guestAccessKey=17c4c146-5861-4afd-9fa5-06599c0a2c55&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123020
What The Viewpoint Says: An unexpected tragedy of the COVID-19 pandemic is increased opioid and fentanyl overdoses, since many factors could have reduced opioid use disorder (OUD) and overdoses during this pandemic. Another tragedy is that both epidemics depend on vaccine development, but antifentanyl vaccine support includes no pharmaceutical and only three government investments, while industry and government support more than 120 COVID-19 vaccines. This discrepancy in support reflects stigma against those with OUD and failure of approved treatments to decrease overdoses.
Authors: Thomas R. Kosten, M.D., of the Baylor College of Medicine in Houston, is the corresponding author.
(doi:10.1001/jamapsychiatry.2020.4148)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2020.5674?guestAccessKey=3de02c94-8257-44ad-8c71-a06b092928e4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123020
Patient Characteristics Associated With Telemedicine Access During COVID-19 Pandemic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 29, 2020
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31640?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122920
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This study identified racial/ ethnic, sex, age, language, and socioeconomic differences in accessing telemedicine for primary care and specialty ambulatory care; if not addressed, these differences may compound existing inequities in care among vulnerable populations.
Authors: Srinath Adusumalli, M.D., M.Sc., of the Hospital of the University of Pennsylvania in Philadelphia, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.31640)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of Case Series of Patients With COVID-19
JAMA Cardiology
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 29, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2020.7308?guestAccessKey=06999ae7-15ab-4b58-a4ce-b8adb0afe5dd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122920
What The Study Did: Severe COVID-19 is characterized by the intense formation of neutrophil extracellular traps (NETs), leading to the blockage of microvessels, as shown in pulmonary samples. The occurrence of ST-elevated myocardial infarction (STEMI) is a serious cardiac manifestation of COVID-19; the intrinsic mechanism of coronary thrombosis appears to still be unknown. This case series report of five patients sought to determine the role of NETs in coronary thrombosis in patients with COVID-19.
Authors: Ana Blasco, M.D., Ph.D., of the Hospital Universitario Puerta de Hierro–Majadahonda in Madrid, Spain, is the corresponding author.
(doi:10.1001/jamacardio.2020.7308)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
One Year Later, How Does COVID-19 Affect Children?
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 28, 2020
Media advisory: The
The JAMA Pediatrics Patient Page is a public service of JAMA Pediatrics and it is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5817?guestAccessKey=c44f8b69-fbbc-44c2-a9c9-39af81887f9e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122820
What The Patient Page Says: We have all lived with COVID-19 for about a year now. Overall, we have learned that children get sick less often than adults, but a few children have gotten severely sick. This update summarizes the current understanding of how children are affected and gives ways to keep families safe as children continue to grow and thrive.
Authors: Lindsay A. Thompson, M.D., M.S., and Sonja A. Rasmussen, M.D., M.S., of the University of Florida College of Medicine in Gainesville, are the authors.
(doi:10.1001/jamapediatrics.2020.5817)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2020.4821?guestAccessKey=24bbf1d4-e70d-4ab1-86ea-09e8d962b2be&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122820
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31357?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122820
Obesity, Eating Disorder Disparities Among Sexual, Gender Minority Children
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 28, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5152?guestAccessKey=74a4437e-1b2d-4316-81cc-38fc295fd57d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122820
What The Study Did: The likelihood of having obesity or eating disorders was compared between sexual and gender minority children ages 9 to 10 and other children in this study.
Authors: Natasha A. Schvey, Ph.D., of the Uniformed Services University of the Health Sciences in Bethesda, Maryland, is the corresponding author.
(doi:10.1001/jamapediatrics.2020.5152)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Carotid Physiology, Neck Restraints in Law Enforcement
JAMA Neurology
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 28, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2020.4669?guestAccessKey=66449aaf-d6c3-4985-bca8-faf46d0271fd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122820
What The Viewpoint Says: This Viewpoint reviews the potential neurologic consequences of any restriction of blood flow or oxygen to the brain and calls for an examination of the safety and appropriateness of the use of neck restraints by law enforcement.
Authors: Altaf Saadi, M.D., M.Sc., of Mass General Brigham, Harvard Medical School in Boston, is the corresponding author.
(doi:10.1001/jamaneurol.2020.4669)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Beverage Prices, Volume Sold After Sweetened Beverage Tax Repeal in Chicago’s County
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 28, 2020
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31083?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122820
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This observational study examined whether lasting change in sweetened beverage prices or the volume sold was associated with the implementation and repeal of a sweetened beverage tax in Cook County, Illinois, where Chicago is.
Authors: Lisa M. Powell, Ph.D., of the University of Illinois Chicago, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.31083)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Comparing Health Outcomes of Privileged Americans With Residents of Other Developed Countries
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 28, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7484?guestAccessKey=ed44c64e-7f8d-430a-9a1d-4b05d2add835&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122820
What The Study Did: Researchers looked at whether health outcomes of white citizens living in the richest U.S. counties were better than that of average individuals in other developed countries.
Authors: Ezekiel J. Emanuel, M.D., Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
(doi:10.1001/jamainternmed.2020.7484)
Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the 1st 6 Months of Pandemic
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 22, 2020
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.8193?guestAccessKey=c3d37109-2bc1-4200-a0a8-94a8c5ce8f8d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122220
What The Study Did: Researchers used data from a large national health insurer in the U.S. to examine whether hospital outcomes for patients with COVID-19 are improving.
Authors: David A. Asch, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
(doi:10.1001/jamainternmed.2020.8193)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessment of Air Contamination by SARS-CoV-2 in Hospital Settings
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 23, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33232?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122320
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: In this systematic review of current evidence on air contamination with SARS-CoV-2 in hospital settings, the air close to and distant from patients with COVID-19 was frequently contaminated with SARS-CoV-2 RNA; however, few of these samples contained viable viruses. High viral loads found in toilets and bathrooms, staff areas and public hallways suggest that these areas should be carefully considered.
Authors: Gabriel Birgand, Ph.D., of the Centre Hospitalo-Universitaire de Nantes in France, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33232)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
FDA Oncology Center of Excellence During COVID-19
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 23, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6783?guestAccessKey=f0b0978e-0660-492a-baaa-08369b85bc7f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122320
What TheViewpoint Says: This Viewpoint discusses initiatives of the U.S. Food and Drug Administration’s Oncology Center of Excellence to address COVID-19-related challenges faced by patients with cancer and the health care professionals who provide cancer treatment.
Authors: Jennifer J. Gao, M.D., of the Oncology Center of Excellence at the FDA in Silver Spring, Maryland, is the corresponding author.
(doi:10.1001/jamaoncol.2020.6783)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.3995?guestAccessKey=3ba8a3f2-fd9d-4fed-909c-813210f88fc1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122320
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30806?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122320
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30473?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122320
Assessing Maternal, Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, Placental Pathology
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 22, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30455?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122020
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This report of maternal viral load, transplacental antibody transmission and placental pathology in 127 pregnancies during the SARS-CoV-2 pandemic provides needed data about maternal viral control, reduced transplacental transfer of anti-SARS-CoV-2 antibodies and lack of vertical transmission in mother-newborn pairs.
Authors: Andrea G. Edlow, M.D., M.Sc., of the Massachusetts General Hospital in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.30455)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Strategies for Adults Experiencing Sheltered Homelessness During COVID-19 Pandemic
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 22, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.28195?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122020
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: In this modeling study of simulated adults living in homeless shelters, daily symptom screening with polymerase chain reaction (PCR) testing of individuals who had positive symptom screening paired with management at a nonhospital care site of people with mild to moderate COVID-19 was associated with a substantial decrease in infections and lowered costs over four months compared with no intervention across a wide range of epidemic scenarios.
Authors: Kenneth A. Freedberg, M.D., M.Sc., of the Massachusetts General Hospital in Boston, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.28195)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.29571?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122220
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30815?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122220
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30189?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122220
Use of Diagnosis Code for COVID-19 Among US Hospitalizations
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 22, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.20323?guestAccessKey=fc391957-6174-4b14-a7af-d3332359922d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122220
What The Study Did: Researchers examined the use of COVID-19-specific coding, the transition from legacy coding and the accuracy of the COVID-19-specific code using SARS-CoV-2 polymerase chain reaction (PCR) testing as the reference standard.
Authors: Ning Rosenthal, M.D., Ph.D., M.P.H., of Premier Healthcare Solutions in Charlotte, North Carolina, is the corresponding author.
(doi:10.1001/jama.2020.20323)
Editor’s Note: The articles includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessing Progress in Health Care Quality Through Lens of COVID-19
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 22, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.17392?guestAccessKey=32bef197-b1cd-4e0d-b1b7-6ea23d54f111&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122220
What The Viewpoint Says: Observations about health system performance during the COVID-19 pandemic are offered in this Viewpoint, with an emphasis on system cohesion and 2 of 3 levels of health care described earlier by the National Academy of Medicine: health care organizational capabilities and the environment of care.
Authors: Carolyn M. Clancy, M.D., of the Discovery, Education and Affiliate Networks (DEAN), Department of Veterans Affairs in Washington, D.C., is the corresponding author.
(doi:10.1001/jama.2020.17392)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Excess Mortality in California During COVID-19 Pandemic
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 21, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7578?guestAccessKey=4b41a8db-cbae-4bb4-a11c-1009fa2ac4be&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122120
What The Study Did: Researchers estimated excess deaths in California between March and August during the COVID-19 pandemic by age, sex, race/ethnicity and educational level. California has a population of more than 39 million, which is about 12% of the U.S. population of 328 million.
Authors: Kirsten Bibbins-Domingo, Ph.D., M.D., M.A.S., of the University of California, SanFrancisco, is the corresponding author.
(doi:10.1001/jamainternmed.2020.7578)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Filled Buprenorphine Prescriptions for Opioid Use Disorder During COVID-19 Pandemic
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 21, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.7497?guestAccessKey=ef436ecf-e2b4-4df0-adfe-d8a288640c59&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122120
What The Study Did: The COVID-19 pandemic has disrupted health care delivery in the United State, and researchers in this study examined changes in total U.S. retail pharmacy sales and sales of buprenorphine products with a U.S. Food and Drug Administration–approved indication for treat- ment of opioid use disorder.
Authors: Thuy D. Nguyen, Ph.D., of the University of Michigan in Ann Arbor, is the corresponding author.
(doi:10.1001/jamainternmed.2020.7497)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.27928?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122120
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.28117?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122120
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5199?guestAccessKey=66e4fbae-a2b0-4214-bfd3-ad7c311e175c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122120
Here’s a link to provide your readers free access to the full-text article
Media advisory: A visual abstract is below.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.27259?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122120
Visual Abstract
(doi:10.1001/jamanetworkopen.2020.30415)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.23130?guestAccessKey=9c13270e-f203-413d-b232-9ac4c58a62d5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122220
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.27259?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=122120
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5211?guestAccessKey=5c99d8f6-f0f6-4639-a23c-688e9ecb0e6b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122120
US Public Attitudes Toward COVID-19 Vaccine Mandates
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, DECEMBER 18, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.33324?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121820
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Researchers assessed the acceptability of COVID-19 vaccine mandates in the U.S. public.
Authors: Emily A. Largent, J.D., Ph.D., R.N., of the University of Pennsylvania Perelman School of Medicine in Philadelphia, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.33324)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 as Leading Cause of Death in US
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full article and an editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24865?guestAccessKey=d0b5e5b7-a997-49c2-9000-c0f1842ce76c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Viewpoint Says: This Viewpoint uses Centers for Disease Control and Prevention data to compare the COVID-19 mortality rate in 2020 with prior leading causes of death (heart disease, cancer, lung disease and injury) to put into context the cost of the infection in loss of life in the United States.
Authors: Steven H. Woolf, M.D., M.P.H., of the Virginia Commonwealth University School of Medicine in Richmond, Virginia, is the corresponding author.
(doi:10.1001/jama.2020.24865)
Editor’s Note: The articles includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30214?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121820
Self-Managed Abortion Attempts Among US Women
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, DECEMBER 18, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.29245?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121820
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Researchers used nationally representative survey data to estimate the proportion of women of reproductive age in the United States who have ever attempted to end an unwanted pregnancy on their own without medical assistance.
Authors: Lauren Ralph, Ph.D., of the University of California San Francisco, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.29245)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
SARS-CoV-2 Infection Among Patients With Cancer Undergoing Antitumor Treatment
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6778?guestAccessKey=08279ad5-1b7e-48a8-9245-69a69a9cc583&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Study Did: The rate of SARS-CoV-2 infection among patients in Italy receiving antitumor treatment was evaluated in this study.
Authors: Carlo Aschele, M.D., Ph.D., of Ospedale Sant’Andrea in La Spezia, Italy, is the corresponding author.
(doi:10.1001/jamaoncol.2020.6778)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19 Social Distancing Efforts: Implications for Cancer Control
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6786?guestAccessKey=28eb8ef2-af95-4069-a4fd-3e5a2dff1e1a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Viewpoint Says: The consequences of COVID-19–related social distancing on health behaviors that may result in better or worse outcomes for patients with cancer are explored in this Viewpoint.
Authors: Rebecca A. Ferrer, Ph.D., of the National Cancer Institute in Rockville, Maryland, is the corresponding author.
(doi:10.1001/jamaoncol.2020.6786)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
COVID-19-Associated Ocular Neuropathy With Panuveitis
JAMA Ophthalmology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.5695?guestAccessKey=f9860caa-636d-4c38-b769-40bb2fbb1c89&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Case Report Says: A case of COVID-19 with severe ocular neuropathy and panuveitis (inflammation) is reported in this article.
Authors: Jean Marc Perone, M.D., of Metz-Thionville Regional Hospital Center, Lorraine University, Mercy Hospital in Metz, France, is the corresponding author.
(doi:10.1001/jamaophthalmol.2020.5695)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Intravitreal Anti–Vascular Endothelial Growth Factor Use in France During COVID-19 Pandemic
JAMA Ophthalmology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.5594?guestAccessKey=4c61f110-140e-479d-a7a6-6f2f22c034ad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Study Did: This study quantified changes in the use of intravitreal (IVT) anti-vascular endothelial growth factors (anti-VEGF), the main treatment for retinal vascular abnormalities, since the COVID-19 pandemic started in France.
Authors: Sophie Billioti de Gage, Pharm.D., P.D., of EPI-PHARE, French National Agency for Medicines and Health Products Safety, French National Health Insurance in Saint-Denis, France, is the corresponding author.
(doi:10.1001/jamaophthalmol.2020.5594)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Outcomes of Early Tracheostomy for Patients With COVID-19
JAMA Otolaryngology–Head & Neck Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.4837?guestAccessKey=f77879b7-a115-4229-b5b7-f1d1a17fa911&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
What The Study Did: A retrospective medical record review was done of 148 patients to assess outcomes from early tracheostomy in the airway management of patients with COVID-19 who required mechanical ventilation.
Authors: Paul E. Kwak, M.D., M.M., M.Sc., of NYU Langone Health in New York, is the corresponding author.
(doi:10.1001/jamaoto.2020.4837)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
All-Cause Excess Mortality, COVID-19–Related Mortality Among US Adults
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 16, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.24243?guestAccessKey=e7e93128-2115-4730-89fb-023c8acfa867&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121620
What The Study Did: Researchers used publicly available data to examine all-cause excess mortality (the gap between observed and expected deaths) and COVID-19-related mortality during the early period of the pandemic among adults ages 25 to 44.
Authors: Jeremy Samuel Faust, M.D., M.S., of Brigham and Women’s Hospital in Boston, is the corresponding author.
(doi:10.1001/jama.2020.24243)
Editor’s Note: The articles includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2020.4835?guestAccessKey=2e0a75ca-0da4-466d-be17-5dfc43c7b569&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720
Nonfatal Opioid Overdoses Among Young People
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30201?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121720
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This observational study examined differences by sex among young people (ages 11 to 24) who experienced nonfatal opioid overdoses.
Authors: Sarah M. Bagley, M.D., M.Sc., of the Boston Medical Center, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.30201)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Suicide Mortality in Maryland During COVID-19 Pandemic
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 16, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.3938?guestAccessKey=e13d47ea-eb7a-42d8-a7a9-75e977ad3d7d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121620
What The Study Did: Differences in suicide deaths by race/ethnicity during the COVID-19 pandemic in Maryland were analyzed in this observational study.
Authors: Paul Sasha Nestadt, M.D., of the Johns Hopkins University School of Medicine in Baltimore, is the corresponding author.
(doi:10.1001/jamapsychiatry.2020.3938)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Suicide Risk Among Patients With Parkinson Disease
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 16, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.4001?guestAccessKey=e79190c7-3846-4228-a7e2-cf61fb96d10f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121620
What The Study Did: Researchers investigated whether Parkinson disease was associated with an increased risk of suicide among a large group of patients in Taiwan.
Authors: Pei-Chen Lee, Ph.D., of the National Taipei University of Nursing and Health Sciences in Taipei, Taiwan, is the corresponding author.
(doi:10.1001/jamapsychiatry.2020.4001)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
UV Exposure, Risk of Melanoma in Skin of Color
JAMA Dermatology
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 16, 2020
Media advisory: The full study and editorial are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.4616?guestAccessKey=cced5a04-3402-42ff-83d7-9fb205f752da&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121620
What The Study Did: The association between ultraviolet (UV) light exposure and the risk of melanoma in individuals with skin of color was examined with a review of the results of 13 studies.
Authors: Adewole S. Adamson, M.D., M.P.P., of the University of Texas at Austin, is the corresponding author.
(doi:10.1001/jamadermatol.2020.4616)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Change in Use, Perceptions of Nicotine Vaping Among US Youth 2017-2020
JAMA Pediatrics
EMBARGOED FOR RELEASE: 9 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5667?guestAccessKey=12592e50-3467-4400-b750-01c37248c0dd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520
What The Study Did: This study estimates how common nicotine vaping is, its perceived harm and the accessibility of nicotine vaping products among U.S. adolescents from 2017 to 2020.
Authors: Richard Miech, Ph.D., of the University of Michigan in Ann Arbor, is the corresponding author.
(doi:10.1001/jamapediatrics.2020.5667)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
What Is an Aerosol-Generating Procedure?
JAMA Surgery
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2020.6643?guestAccessKey=849aa5c2-f6cf-4e6a-a018-14aa20bd0c56&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520
What The Viewpoint Says: The SARS-CoV-2 pandemic has brought renewed urgency to the question of what constitutes an aerosol-generating procedure. Four factors that explain transmission risk during aerosol-generating medical procedures are discussed in this article.
Authors: Michael Klompas, M.D., M.P.H., of Harvard Pilgrim Health Care Institute and Harvard Medical School in Boston, is the corresponding author.
(doi:10.1001/jamasurg.2020.6643)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Maximizing the Uptake of a COVID-19 Vaccine in People With Severe Mental Illness
JAMA Psychiatry
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2020.4396?guestAccessKey=a8d54ad2-d65c-4e9b-8175-7a85d3594da5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520
What The Viewpoint Says: This Viewpoint discusses individual- and system-level barriers and solutions for people with serious mental illness to access COVID-19 vaccination when it is available.
Authors: Nicola Warren, M.B.B.S., of the University of Queensland and Metro South Addiction and Mental Health in Brisbane, Queensland, Australia, is the corresponding author.
(doi:10.1001/jamapsychiatry.2020.4396)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.29650?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121520
Treatment of Opioid Use Disorder Among Commercially Insured Patients in Context of COVID-19 Pandemic
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.21512?guestAccessKey=07d7e6a6-d1c1-4ab2-a9a8-220eeb6674e2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520
What The Study Did: Opioid use disorder treatment during the early months of the COVID-19 pandemic, including medication fills, outpatient visits and urine tests among privately insured individuals, was compared with 2019 in this study.
Authors: Haiden A. Huskamp, Ph.D., of Harvard Medical School in Boston, is the corresponding author.
(doi:10.1001/jama.2020.21512)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Changes in Outpatient Buprenorphine Dispensing During COVID-19 Pandemic
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22154?guestAccessKey=8e93d93e-c5cf-4886-8646-e4a0479a067e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121520
What The Study Did: Outpatient buprenorphine dispensing patterns in Texas before and after the Drug Enforcement Administration temporarily relaxed outpatient buprenorphine prescribing regulations in March 2020 in response to the COVID-19 pandemic were examined in this study.
Authors: Jessica Duncan Cance, M.P.H., Ph.D., of RTI International in Research Triangle Park, North Carolina, is the corresponding author.
(doi:10.1001/jama.2020.22154)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
USPSTF Statement on Screening for Hepatitis B Virus Infection in Adolescents, Adults
JAMA
EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, DECEMBER 15, 2020
Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 202-572-2044. The full report and related articles are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.22980?guestAccessKey=2e1cb4e4-c9e3-4ee7-b119-b5bb822c7f76&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121420
Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends screening for hepatitis B virus infection in adolescents and adults at increased risk for infection. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement is consistent with the 2014 recommendation and strengthened by new evidence from trials and cohort studies reporting that antiviral therapy reduces risk of mortality and hepatocellular carcinoma and improves intermediate outcomes that are consistently associated with better health outcomes.
(doi:10.1001/jama.2020.22980)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.
Household Transmission of SARS-CoV-2
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 14, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31756?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121420
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: The findings of this study suggest households will continue to be a significant venue for transmission of SARS-CoV-2 because people with suspected or confirmed infections are being told to isolate at home.
Authors: Zachary J. Madewell, of the University of Florida in Gainesville, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.31756)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Clinical Characteristics, Disease Severity Among Infants With SARS-CoV-2 Infection
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 14, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.30470?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121420
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This study describes the manifestations and severity of disease among infants with SARS-CoV-2 infection.
Authors: Fatima Kakkar, M.D., M.P.H., of the Centre Hospitalier Universitaire Sainte-Justine in Montreal, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.30470)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Allocating Resources Across Life Span During COVID-19
JAMA Pediatrics
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 14, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.5215?guestAccessKey=f9c88a94-b3cb-4017-8acf-a8f9cc228a9d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121420
What The Viewpoint Says: This Viewpoint discusses the need to account for neonates and children, who are typically disproportionally impacted during pandemics, by implementing hospital resource allocation protocols that ensure equity across the life span.
Authors: Monica E. Lemmon, M.D., of the Duke University School of Medicine in Durham, North Carolina, is the corresponding author.
(doi:10.1001/jamapediatrics.2020.5215)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Association of Political Party Affiliation With Physical Distancing Among Young Adults During COVID-19 Pandemic
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 14, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.6898?guestAccessKey=196d4681-0ebf-4a1a-8d23-49ce45d25d44&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121420
What The Study Did: Researchers estimated the associations of political party affiliation with physical distancing behaviors among young adults, a population with high rates of COVID-19.
Authors: Adam M. Leventhal, Ph.D., of the Keck School of Medicine at the University of Southern California in Los Angeles, is the corresponding author.
(doi:10.1001/jamainternmed.2020.6898)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Diversity, Representation of Physicians During COVID-19 News Cycle
JAMA Internal Medicine
EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, DECEMBER 14, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2020.6285?guestAccessKey=12c1d211-3675-4258-9f17-0317564a0163&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121420
What The Study Did: The diversity of speakers who discussed COVID-19 and other content on three popular American cable news networks (Fox News Network, CNN and MSNBC) was investigated in this study.
Authors: Reshma Jagsi, M.D., D.Phil., of the University of Michigan in Ann Arbor, was the corresponding author.
(doi:10.1001/jamainternmed.2020.6285)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.28894?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121020
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.29063?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121020
Risk Factors Associated With In-Hospital Mortality in US National Sample of Patients With COVID-19
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.29058?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121020
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: Patients with COVID-19 who were treated in U.S. hospitals are described in this study that examines risks factors associated with in-hospital death.
Authors: Ning Rosenthal, M.D., Ph.D., M.P.H., of Premier Applied Sciences in Charlotte, North Carolina, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.29058)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
German Public Attitudes Toward Health Communications Regarding COVID-19
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.32335?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121020
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This survey study assessed attitudes of the German public regarding COVID-19 health communications with varying degrees of scientific uncertainty.
Authors: Odette Wegwarth, Ph.D., of the Max Planck Institute for Human Development in Berlin, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.32335)
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Assessment of Online Tool to Simulate Effect of Pooled Testing for SARS-CoV-2
JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2020.31517?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=121020
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: A diagnostic study, this describes an online tool created with actual SARS-CoV-2 virus copy number data to help policy makers understand how pooled testing compares with single-sample testing in different populations.
Authors: Michael B. Datto, M.D., Ph.D., of the Duke Health System Clinical Laboratories in Durham, North Carolina, is the corresponding author.
(doi:10.1001/jamanetworkopen.2020.31517)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Analyses of Risk, Racial Disparity, Outcomes Among US Patients With Cancer, COVID-19 Infection
JAMA Oncology
EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6178?guestAccessKey=d71b15c9-b581-42d2-8430-36d812393207&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121020
What The Study Did: This study investigated how patients with specific types of cancer are at risk for COVID-19 infection and its adverse outcomes and whether there are cancer-specific race disparities for COVID-19 infection.
Authors: Nathan A. Berger, M.D., and Rong Xu, Ph.D., of Case Western Reserve University in Cleveland, are the corresponding authors.
(doi:10.1001/jamaoncol.2020.6178)
Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.
Scientific Rigor in COVID-19 Age
JAMA Oncology
EEMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020
Media advisory: The full article is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6639?guestAccessKey=a99b0027-c0c4-46f9-a736-97205cc977b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121020
What The Article Says: This Viewpoint discusses the need for scientific rigor in studies related to COVID-19 and presents study design recommendations and methodologies that should be incorporated to ensure that findings are reliable and reproducible.
Authors: Yu Shyr, Ph.D., of Vanderbilt University Medical Center in Nashville, Tennessee, is the corresponding author.
(doi:10.1001/jamaoncol.2020.6639)
Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.